Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

710
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
710
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

1.7K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.7K
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

7.2K
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
7.2K
Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

787
Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin,...
787
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

6.1K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.1K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.6K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Personalized Medicine Approach is Best for Patients with Homozygous Familial Hypercholesterolemia.

Medical research archives·2025
Same author

Case report: dyslipidaemia-dramatic increase in haemoglobin A1c following statin initiation.

European heart journal. Case reports·2024
Same author

Correction to: Recognition and Treatment of Homozygous Familial Hypercholesterolemia by Primary Care Physicians: a Survey from the National Lipid Association.

Journal of general internal medicine·2020
Same author

A retrospective analysis of clinical use of alirocumab in lipoprotein apheresis patients.

Journal of clinical lipidology·2020
Same author

Recognition and Treatment of Homozygous Familial Hypercholesterolemia by Primary Care Physicians: a Survey from the National Lipid Association.

Journal of general internal medicine·2020
Same author

Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome.

The New England journal of medicine·2019

Related Experiment Video

Updated: Mar 2, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.8K

Lipoprotein(a): A Lipoprotein Whose Time Has Come.

Erik Kelly1, Linda Hemphill2

  • 1Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.

Current Treatment Options in Cardiovascular Medicine
|May 17, 2017
PubMed
Summary

Elevated lipoprotein(a) [Lp(a)] is a key risk factor for cardiovascular disease (CVD) and aortic stenosis, even after LDL-C lowering. New targeted therapies are needed to reduce Lp(a) and residual CVD risk.

Keywords:
Aortic stenosisCardiovascular riskLipid screeningLipid therapiesLipoprotein(a)

More Related Videos

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

12.6K
High-Density Lipoprotein-Specific Phospholipid Efflux Assay
07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

513

Related Experiment Videos

Last Updated: Mar 2, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.8K
Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

12.6K
High-Density Lipoprotein-Specific Phospholipid Efflux Assay
07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

513

Area of Science:

  • Cardiology
  • Biochemistry
  • Pharmacology

Background:

  • Cardiovascular disease (CVD) remains a primary cause of death globally.
  • Despite effective low-density lipoprotein cholesterol (LDL-C) lowering therapies, residual CVD risk persists in many patients.
  • Elevated lipoprotein(a) [Lp(a)] is an independent CVD risk factor and contributes to this residual risk.

Purpose of the Study:

  • To review the role of lipoprotein(a) [Lp(a)] as a causal risk factor for cardiovascular disease (CVD), aortic stenosis, and peripheral arterial disease.
  • To discuss the limitations of current therapeutic options for reducing Lp(a) levels.
  • To highlight the need for targeted Lp(a)-lowering strategies.

Main Methods:

  • Review of existing clinical trial data and scientific literature.
  • Analysis of the causal relationship between Lp(a) and specific cardiovascular conditions.
  • Discussion of current management strategies for elevated Lp(a).

Main Results:

  • Elevated Lp(a) is a confirmed independent risk factor for CVD, aortic stenosis, and peripheral arterial disease.
  • Current therapies primarily focus on managing other risk factors like LDL-C, with limited success in addressing Lp(a)]-driven risk.
  • Existing treatment options for directly lowering Lp(a) are limited.

Conclusions:

  • Lipoprotein(a) [Lp(a)] represents a significant, genetically determined risk factor for cardiovascular disease (CVD) and related conditions.
  • Aggressively managing modifiable risk factors is the current approach, but its efficacy for Lp(a)]-related risk is debated.
  • Targeted therapies aimed at directly reducing Lp(a) are under active investigation and are crucial for addressing residual CVD risk.